Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report.
Fujita Y, Nawata M, Nagayasu A, Someya K, Saito K, Tanaka Y. Fujita Y, et al. Case Rep Rheumatol. 2019 Jul 9;2019:5293981. doi: 10.1155/2019/5293981. eCollection 2019. Case Rep Rheumatol. 2019. PMID: 31360575 Free PMC article.
TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus.
Shan Y, Nakayamada S, Nawata A, Yamagata K, Sonomoto K, Tanaka H, Satoh-Kanda Y, Nguyen MP, Todoroki Y, Nagayasu A, Ueno M, Kanda R, Fujita Y, Zhang T, Hao H, Zhou J, Ma X, Anan J, Nguyen AP, Tanaka Y. Shan Y, et al. Among authors: fujita y. Rheumatology (Oxford). 2023 Jul 5;62(7):2464-2474. doi: 10.1093/rheumatology/keac646. Rheumatology (Oxford). 2023. PMID: 36370078
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Sonomoto K, Nakayamada S, Fujino Y, Miyata H, Kubo S, Fujita Y, Inoue Y, Matsunaga S, Iwata S, Hanami K, Todoroki Y, Yoshinari-Korekoda H, Kawabe A, Yamaguchi A, Ueno M, Satoh-Kanda Y, Kanda R, Funada M, Ohkubo N, Kusaka K, Kosaka S, Nagayasu A, Fukuyo S, Nawata M, Miyazaki Y, Tokunaga M, Tanaka K, Okada Y, Tanaka Y. Sonomoto K, et al. Among authors: fujita y. Rheumatology (Oxford). 2023 Nov 2:kead579. doi: 10.1093/rheumatology/kead579. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37934120
Pharmacokinetics of denopamine in hemodialysis patients.
Nakahama H, Izumi M, Tanaka Y, Wada A, Fujita Y, Orita Y, Shirai D, Kamada T. Nakahama H, et al. Among authors: fujita y. Ren Fail. 1991;13(1):37-41. doi: 10.3109/08860229109022145. Ren Fail. 1991. PMID: 1681572
Evaluation of hemodialysis efficiency by an edema fluid model.
Shirai D, Kajimoto Y, Ochi S, Tanaka Y, Wada A, Yano F, Izumi M, Fujita Y, Nakahama H. Shirai D, et al. Among authors: fujita y. Ren Fail. 1992;14(1):63-8. doi: 10.3109/08860229209039118. Ren Fail. 1992. PMID: 1561390
4,383 results